Panelists discuss financial obstacles, out-of-pocket costs, prior authorizations, and the inpatient/outpatient care paradigm.
5 First-in-Class, First-in-Disease FDA Approvals From August
From respiratory conditions to rare diseases and beyond, here are 5 groundbreaking FDA approvals from last month.
Read More
High Costs, Coverage Variability Limit Access to Incretin Mimetics for Weight Management
This Managed Care Cast episode explores how high costs and inconsistent insurance coverage for incretin mimetics impact obesity management and patient care.
Listen
Individuals With HIV Have an Increased Risk of Osteoporosis
Bone density was found to be lower in those diagnosed with HIV vs those who were HIV-negative.
Five Years Later: Ongoing COVID-19 Challenges, Next Steps
On this episode of Managed Care Cast, we speak with Jenny Han, MD, of Emory School of Medicine and Grady Hospital, about COVID-19, long COVID, and strategies for prevention and care.
Survival Outcomes in Advanced NSCLC Improved With Use of Cemiplimab
The use of cemiplimab with chemotherapy showed durable improvements in survival outcomes for non-small cell lung cancer (NSCLC) after 5 years.
Biomarker Insights Differentiate JAK1 vs IL-13 Therapy in AD
AD-related outcomes were compared in patients treated with JAK1 inhibitors and IL-13 antibodies, with short-term efficacy biomarkers considered for treatment outcomes.